Susquehanna International Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.82M Buy
243,200
+47,200
+24% +$1.15M ﹤0.01% 3974
2025
Q4
$4.44M Sell
196,000
-61,500
-24% -$1.34M ﹤0.01% 4214
2025
Q3
$5.19M Buy
257,500
+36,100
+16% +$605K ﹤0.01% 4031
2025
Q2
$3.16M Sell
221,400
-102,200
-32% -$1.19M ﹤0.01% 4857
2025
Q1
$3.4M Sell
323,600
-62,400
-16% -$706K ﹤0.01% 4392
2024
Q4
$4.67M Sell
386,000
-172,700
-31% -$2.26M ﹤0.01% 3701
2024
Q3
$8.21M Buy
558,700
+38,800
+7% +$541K ﹤0.01% 2884
2024
Q2
$7.5M Sell
519,900
-528,400
-50% -$8.44M ﹤0.01% 2844
2024
Q1
$17.1M Buy
1,048,300
+561,800
+115% +$8.78M ﹤0.01% 1962
2023
Q4
$7.25M Buy
486,500
+213,900
+78% +$2.42M ﹤0.01% 3108
2023
Q3
$3.06M Buy
272,600
+148,200
+119% +$1.72M ﹤0.01% 4343
2023
Q2
$1.25M Buy
124,400
+8,300
+7% +$77K ﹤0.01% 6177
2023
Q1
$1.09M Buy
116,100
+8,500
+8% +$100K ﹤0.01% 6581
2022
Q4
$1.31M Sell
107,600
-355,000
-77% -$4.42M ﹤0.01% 5584
2022
Q3
$5.74M Buy
462,600
+241,200
+109% +$4.22M ﹤0.01% 2945
2022
Q2
$4.35M Sell
221,400
-45,200
-17% -$1.07M ﹤0.01% 3420
2022
Q1
$6.96M Buy
266,600
+32,500
+14% +$866K ﹤0.01% 3097
2021
Q4
$6.64M Sell
234,100
-116,000
-33% -$3.61M ﹤0.01% 3288
2021
Q3
$11.2M Sell
350,100
-253,400
-42% -$8.5M ﹤0.01% 2711
2021
Q2
$20.9M Buy
603,500
+279,700
+86% +$9.22M ﹤0.01% 1974
2021
Q1
$9.54M Sell
323,800
-112,500
-26% -$3.46M ﹤0.01% 2843
2020
Q4
$13.4M Buy
436,300
+142,100
+48% +$4.34M ﹤0.01% 2156
2020
Q3
$8.22M Sell
294,200
-167,100
-36% -$4.23M ﹤0.01% 2423
2020
Q2
$9.89M Buy
461,300
+4,600
+1% +$102K ﹤0.01% 2146
2020
Q1
$10.2M Buy
456,700
+130,800
+40% +$3.58M ﹤0.01% 1720
2019
Q4
$9.6M Buy
325,900
+27,900
+9% +$758K ﹤0.01% 2124
2019
Q3
$7.92M Buy
298,000
+28,900
+11% +$867K ﹤0.01% 2216
2019
Q2
$9.1M Sell
269,100
-98,200
-27% -$3.19M ﹤0.01% 1983
2019
Q1
$11.8M Buy
+367,300
New +$11.3M ﹤0.01% 1589

Other funds holding ELAN

Susquehanna International Group's ELAN Position: Q1 2026 in Review

Susquehanna International Group increased its Elanco Animal Health (ELAN) stake by 16% in Q1 2026, buying an estimated $190K and bringing the position to 56,808 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #7132.

Susquehanna International Group first reported a position in ELAN in Q4 2018 and has held it in 30 quarters since. The position peaked at $81M in Q1 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Susquehanna International Group held 56,808 shares of Elanco Animal Health worth $1.36M as of Q1 2026.
  • Susquehanna International Group bought 7,792 Elanco Animal Health shares in Q1 2026, an estimated $190K.
  • Elanco Animal Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7132 holding.
  • Susquehanna International Group first reported a position in Elanco Animal Health in Q4 2018 and has held it in 30 quarters since.
  • Susquehanna International Group's Elanco Animal Health position peaked at $81M in Q1 2019.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.